๐ฐ Greg Seeto News
Page 4 - Greg Seeto News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Greg Seeto. Real-time updates on events, politics, business and more.
May 11, 2022
Posters and Symposium Feature Latest Advances in AlloSeq Portfolio Including HLA Typing and Hematopoietic Stem Cell and Organ Transplant MonitoringSOUTH SAN FRANCISCO, Calif., May 11, 2022 (GLOBE NEWSWIRE)
May 11, 2022
Posters and Symposium Feature Latest Advances in AlloSeq Portfolio Including HLA Typing and Hematopoietic Stem Cell and Organ Transplant Monitoring...
April 28, 2022
SOUTH SAN FRANCISCO, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) โ The Transplant Companyโข focused on the discovery,...
April 27, 2022
/PRNewswire/ -- The International Society for Heart and Lung Transplantation (ISHLT) has established a new sister organization: the ISHLT Foundation. This new...
April 27, 2022
/PRNewswire/ -- The International Society for Heart and Lung Transplantation (ISHLT) has established a new sister organization: the ISHLT Foundation. This new...
April 22, 2022
CareDx Demonstrates Potential of AlloHeme and AlloCell for Allogeneic Cell Transplant and Therapy Monitoring at Transplantation & Cellular Therapy Meetings - read this article along with other careers information, tips and advice on BioSpace
April 21, 2022
A new initiative called Pluralist will challenge the current paradigm and pursue equity in organ transplantation. The effort will place particular emphasis on c
April 10, 2022
Symposium, โImproved Precision with a Multimodality Approach,โ Reviews Innovative Solutions for a More Holistic View of Allograft Health...
April 6, 2022
SOUTH SAN FRANCISCO, Calif., April 06, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare
March 30, 2022
SOUTH SAN FRANCISCO, Calif., March 30, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) - The Transplant Company focused on the discovery, development, and commercialization of clinically differentiated